Ronesans Gayrimenkul Q3 Revenue Rises to 4.8 Billion Lira
Q3 revenue was 4.8 billion lira, compared with 4.0 billion lira a year earlier.
Related stories
U.S. Airline Shares Rise as Oil Prices Fall
Oil prices fell, easing concerns about airline fuel costs as U.S. airline shares rose.
L impact | EQUITY | Nov 04, 2026, 04:08 PM UTC
NYSE American single-stock trading halt, symbol not given — additional information requested (last $7.23)
NYSE American halted trading in a single listed security (additional information requested). Last price $7.23.
L impact | EQUITY | Nov 04, 2026, 04:08 PM UTC
Siltronic CEO Says AI Boom Diverts Chip Supply From Smartphones, PCs
CEO Michael Heckmeier said semiconductor supply is shifting toward data centres and away from smartphones and PCs, constraining some end markets. The body is truncated after saying
M impact | EQUITY | Nov 04, 2026, 04:07 PM UTC
Garuda Indonesia Plans Rights Issue to Acquire 65.77% GMFI Stake
Garuda Indonesia plans a rights issue to acquire a 65.77% stake in GMFI as part of a financial restructuring.
M impact | EQUITY | Nov 04, 2026, 04:07 PM UTC
Saudi Aramco Acquires 49% Stake in Humain
Saudi Aramco acquired a 49% stake in state-owned Humain.
M impact | EQUITY | Nov 04, 2026, 04:07 PM UTC
Moleculin Reports Interim AML Trial Remission Rates of 43% and 36%
Among the first 45 randomized patients, complete remission rates were 43% and 36% in the two Annamycin arms, versus 12% with placebo. The Data Monitoring Committee recommended cont
M impact | EQUITY | Nov 04, 2026, 04:07 PM UTC